News in tagged with „spin-off“

Heidelberg, Germany, July 23, 2015 – BioMed X Innovation Center announced today that they have extended their collaboration with Merck Serono, the biopharmaceuticals business of Merck, on new approaches for cancer therapy. Based on …

Heidelberg, Germany, March 30, 2015 – AbbVie and BioMed X announced today that they have entered into a collaboration agreement to establish a research group focusing on new treatment options of tau pathology in …

Germany, February 24, 2015 – Roche and BioMed X announced today that they have entered into a collaboration agreement to establish a research group focusing on the development of a novel sensor technology platform …

Heidelberg, Germany, January 5, 2015 – BioMed X announced today that they have entered into a collaboration agreement with Boehringer Ingelheim to establish a research group focusing on the identification of novel therapeutic concepts …

Open Innovation describes an innovation culture that aims to integrate talented individuals from outside the company into the development of new products. Merck and BioMed X GmbH, which is based in Heidelberg, Germany, have …

BioMed X GmbH, founded in Heidelberg in March 2013, and Merck KGaA from Darmstadt have established a new way of fostering innovation at the interface of academic biomedical research and pharmaceutical industry-based research.
Teams of …

We use cookies and other tracking technologies to improve your browsing experience on our site, provide social media features and to analyze site traffic. We also share information about your use of our site with our social media and analytics partners who may combine it with other information that you've provided to them or that they've collected from your use of their services. By choosing I Accept, you consent to our use of cookies and other tracking technologies in accordance with our Privacy Policy.